Word

DIAGNOSTICS DEFINING THERAPY

Status

Registered

Status Code

700

Status Date

Tuesday, April 28, 2020

Serial Number

79259148

Registration Number

6039262

Registration Date

Tuesday, April 28, 2020

Mark Type

4000

Filing Date

Friday, December 21, 2018

Published for Opposition

Tuesday, February 11, 2020

Trademark Owner History

SpeeDx Pty Ltd - Original Registrant

Classifications

5 Pharmaceutical and veterinary preparations and substances; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use; chemical preparations containing enzymes for medical purposes for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and/or immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and/or analysis of epigenetic alterations, analysis of response to therapy; chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and/or immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and/or analysis of epigenetic alterations, analysis of response to therapy; enzymes for pharmaceutical, veterinary and medical purposes; medical kits containing medical and/or pharmaceutical preparations and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; clinical diagnostics for medical or veterinary use; biological chemical test kits for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders

1 Chemicals used in industry, science, photography, agriculture, horticulture and forestry, except fungicides, herbicides, insecticides, and parasiticides; reagents and reactants for non-medical purposes; enzymes for industrial or scientific purposes; nucleic acid for other than medical and veterinary purposes; nucleic recombinant acids for other than medical and veterinary purposes; acids, namely inorganic acids for industrial purposes; DNA polymerase; chemicals used in food processing and screening; chemicals used in environmental monitoring

44 Medical services; human healthcare services; medical testing services relating to the diagnosis and treatment of disease; genetic testing for medical purposes; medical and health services relating to dna, genetics and genetic testing; medical diagnostic services in the nature of medical testing and medical analysis; providing collected and analysed medical information in the field of genetic and treatment information for diseases and disorders for diagnostic and treatment purposes; diagnostic imaging for medical purposes and molecular medicine healthcare services

10 Surgical, medical and veterinary apparatus and instruments; diagnostic testing apparatus and instruments for medical purposes; diagnostic testing kits containing diagnostic testing apparatus; point of care medical devices; screening kits in this class comprised of medical screening and testing apparatus for the diagnosis of disease, detection and/or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and/or immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and/or analysis of epigenetic alterations, analysis of response to therapy

42 Scientific and technological services and research and design relating thereto, namely, DNA analysis services for scientific research purposes, and scientific research consulting in the field of genetics; genetic research; genetic engineering services; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; chemistry services, namely, chemistry research services; research relating to chemistry; scientific research relating to chemistry; research in the field of chemistry; laboratory analysis in the field of chemistry; development of diagnostic apparatus for genetics research; design of diagnostic apparatus for genetics research; research relating to molecular sciences; analysis of data generated by scientific and medical experiments and tests; biological, bacteriological, chemical, biochemical, dna, rna, protein, polynucleic acid and molecular analysis and evaluation services; dna and rna and polynucleic acid and protein sequencing, analysis and evaluation services; genome sequencing services and the analysis and evaluation of data resulting therefrom; scientific analysis and the provision of reports in conjunction therewith relating to scientific and medical experiments, the results of scientific and medical experiments and tests, the analysis and evaluation of scientific and medical data, and data generated by scientific and medical experiments and tests; scientific and medical research and development services; custom design and development of biochemical assays; molecular diagnostics testing

"DIAGNOSTICS"

Trademark Events

Aug 8, 2022

Teas Change Of Correspondence Received

Aug 8, 2022

Attorney/Dom.Rep.Revoked And/Or Appointed

Aug 8, 2022

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Aug 13, 2021

Change Of Name/Address Rec'd From Ib

Sep 26, 2020

Final Decision Transaction Processed By Ib

Sep 6, 2020

Final Disposition Notice Sent To Ib

Aug 31, 2020

Final Disposition Processed

Jul 28, 2020

Final Disposition Notice Created, To Be Sent To Ib

Apr 28, 2020

Registered-Principal Register

Feb 14, 2020

Notification Processed By Ib

Feb 11, 2020

Official Gazette Publication Confirmation E-Mailed

Feb 11, 2020

Published For Opposition

Jan 29, 2020

Notification Of Possible Opposition Sent To Ib

Jan 29, 2020

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Jan 22, 2020

Notification Of Notice Of Publication E-Mailed

Jan 7, 2020

Approved For Pub - Principal Register

Dec 19, 2019

Attorney/Dom.Rep.Revoked And/Or Appointed

Dec 19, 2019

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Dec 18, 2019

Teas/Email Correspondence Entered

Dec 17, 2019

Correspondence Received In Law Office

Dec 17, 2019

Teas Response To Office Action Received

Jul 12, 2019

Refusal Processed By Ib

Jun 24, 2019

Non-Final Action Mailed - Refusal Sent To Ib

Jun 24, 2019

Refusal Processed By Mpu

Jun 5, 2019

Non-Final Action (Ib Refusal) Prepared For Review

Jun 4, 2019

Non-Final Action Written

Jun 1, 2019

Application Filing Receipt Mailed

May 28, 2019

Assigned To Examiner

May 28, 2019

New Application Office Supplied Data Entered In Tram

May 23, 2019

Sn Assigned For Sect 66a Appl From Ib